29588002: Brompheniramine maleate (substance)

SNOMED CT Concept\Substance\...

\Substance categorized by disposition\Substance with receptor antagonist mechanism of action (substance)\Histamine receptor antagonist\Propylamine derivative antihistamine\Brompheniramine maleate

\Substance categorised by structure\Chemical\Chemical categorized by structure (substance)\...

\Nitrogen and/or nitrogen compound (substance)\Nitrogen compound\Organic nitrogen compound\Amine and/or amine derivative\Propylamine\Propylamine derivative antihistamine\Brompheniramine maleate

\Organic compound\Organic nitrogen compound\Amine and/or amine derivative\Propylamine\Propylamine derivative antihistamine\Brompheniramine maleate

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT core

Descriptions:

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Brompheniramine maleate	Is a	Product containing brompheniramine (medicinal product)	false	Inferred relationship	Some
Brompheniramine maleate	Is a	Brompheniramine (substance)	false	Inferred relationship	Some
Brompheniramine maleate	This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context.	Histamine receptor antagonist (disposition)	true	Inferred relationship	Some
Brompheniramine maleate	Is a	Propylamine derivative antihistamine	true	Inferred relationship	Some
Brompheniramine maleate	This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged.	Brompheniramine (substance)	true	Inferred relationship	Some

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
brompheniraminmaleat + codeinphosphat + phenylpropanolaminhydrochlorid 2 mg/5 ml 10 mg/5 ml 12,5 mg/5 ml syrup	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Brompheniramine maleate	Inferred relationship	Some
brompheniraminmaleat + dextromethorphanhydrobromid + pseudoephedrinhydrochlorid 2 mg/5 ml 10 mg/5 ml 30 mg/5 ml syrup	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Brompheniramine maleate	Inferred relationship	Some
brompheniraminmaleat + dextromethorphanhydrobromid + pseudoephedrinhydrochlorid 4 mg/5 ml 15 mg/5 ml 60 mg/5 ml syrup	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Brompheniramine maleate	Inferred relationship	Some
brompheniraminmaleat + dextromethorphanhydrobromid + pseudoephedrinhydrochlorid 4 mg/5 ml 15 mg/5 ml 45 mg/5 ml syrup	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Brompheniramine maleate	Inferred relationship	Some
brompheniraminmaleat 4 mg/5 ml + dextromethorphanhydrobromid 30 mg/5 ml + pseudoephedrinhydrochlorid 60 mg/5 ml syrup	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Brompheniramine maleate	Inferred relationship	Some
brompheniraminmaleat + codeinphosphat + phenylpropanolaminhydrochlorid	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Brompheniramine maleate	Inferred relationship	Some
brompheniraminmaleat + dextromethorphanhydrobromid + phenylpropanolaminhydrochlorid	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Brompheniramine maleate	Inferred relationship	Some
brompheniraminmaleat + phenylpropanolamin	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Brompheniramine maleate	Inferred relationship	Some
brompheniraminmaleat + pseudoephedrin + paracetamol	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Brompheniramine maleate	Inferred relationship	Some
brompheniraminmaleat + phenylephrin + phenylpropanolamin	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Brompheniramine maleate	Inferred relationship	Some
brompheniraminmaleat + dextromethorphanhydrobromid + phenylpropanolaminhydrochlorid 2 mg/5 ml 10 mg/5 ml 12,5 mg/5 ml syrup	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Brompheniramine maleate	Inferred relationship	Some
brompheniraminmaleat 2 mg + dextromethorphanhydrobromid 10 mg + phenylpropanolaminhydrochlorid 12,5 mg væske	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Brompheniramine maleate	Inferred relationship	Some
brompheniraminmaleat 2 mg + guaifenesin 200 mg + hydrocodonhydrogentartrat 5 mg syrup	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Brompheniramine maleate	Inferred relationship	Some
brompheniraminmaleat 2 mg + hydrocodonhydrogentartrat 1,7 mg + pseudoephedrinhydrochlorid 30 mg	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Brompheniramine maleate	Inferred relationship	Some
brompheniraminmaleat + dextromethorphanhydrobromid + pseudoephedrinhydrochlorid	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Brompheniramine maleate	Inferred relationship	Some
brompheniraminmaleat + hydrocodonhydrogentartrat + pseudoephedrinhydrochlorid	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Brompheniramine maleate	Inferred relationship	Some
brompheniraminmaleat 2 mg/5 ml eliksir	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Brompheniramine maleate	Inferred relationship	Some
brompheniraminmaleat + pseudoephedrinhydrochlorid 16 mg/240 mg tablet med modificeret udløsning	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Brompheniramine maleate	Inferred relationship	Some
brompheniraminmaleat 10 mg/1 ml injektionsvæske, hætteglas a 10 ml	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Brompheniramine maleate	Inferred relationship	Some
brompheniraminmaleat	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Brompheniramine maleate	Inferred relationship	Some
Brompheniramine maleate 6 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Brompheniramine maleate	Inferred relationship	Some
brompheniraminmaleat 10 mg/ml injektionsvæske, opløsning, ampul	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Brompheniramine maleate	Inferred relationship	Some
Product containing precisely brompheniramine 12 milligram and pseudoephedrine hydrochloride 120 milligram/1 each conventional release oral capsule (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Brompheniramine maleate	Inferred relationship	Some
Product containing precisely brompheniramine 6 milligram and pseudoephedrine hydrochloride 60 milligram/1 each conventional release oral capsule (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Brompheniramine maleate	Inferred relationship	Some
Brompheniramine maleate + pseudoephedrine hydrochloride	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Brompheniramine maleate	Inferred relationship	Some
Brompheniramine maleate 6 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Brompheniramine maleate	Inferred relationship	Some	1
Brompheniramine maleate 6 mg oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Brompheniramine maleate	Inferred relationship	Some	1
Brompheniramine maleate + pseudoephedrine hydrochloride 16mg/240mg prolonged-release oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Brompheniramine maleate	Inferred relationship	Some
Brompheniramine maleate 6 mg oral tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Brompheniramine maleate	Inferred relationship	Some	1
Product containing precisely brompheniramine maleate 400 microgram/1 milliliter conventional release oral solution (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Brompheniramine maleate	Inferred relationship	Some	1
Product containing precisely brompheniramine maleate 400 microgram/1 milliliter conventional release oral solution (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Brompheniramine maleate	Inferred relationship	Some	1
Brompheniramine maleate 400 microgram/mL and guaifenesin 40 mg/mL and hydrocodone bitartrate 1 mg/mL oral solution	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Brompheniramine maleate	Inferred relationship	Some	1
Brompheniramine maleate 400 microgram/mL and guaifenesin 40 mg/mL and hydrocodone bitartrate 1 mg/mL oral solution	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Brompheniramine maleate	Inferred relationship	Some	1
Product containing precisely brompheniramine maleate 10 milligram/1 milliliter conventional release solution for injection (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Brompheniramine maleate	Inferred relationship	Some	1
Product containing precisely brompheniramine maleate 10 milligram/1 milliliter conventional release solution for injection (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Brompheniramine maleate	Inferred relationship	Some	1
Product containing precisely brompheniramine maleate 800 microgram/1 milliliter and dextromethorphan hydrobromide 3 milligram/1 milliliter and pseudoephedrine hydrochloride 9 milligram/1 milliliter conventional release oral solution (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Brompheniramine maleate	Inferred relationship	Some	2
Product containing precisely brompheniramine maleate 800 microgram/1 milliliter and dextromethorphan hydrobromide 3 milligram/1 milliliter and pseudoephedrine hydrochloride 9 milligram/1 milliliter conventional release oral solution (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Brompheniramine maleate	Inferred relationship	Some	2
Brompheniramine maleate 400 microgram/mL and dextromethorphan hydrobromide 2 mg/mL and pseudoephedrine hydrochloride 6 mg/mL oral solution	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Brompheniramine maleate	Inferred relationship	Some	2
Brompheniramine maleate 400 microgram/mL and dextromethorphan hydrobromide 2 mg/mL and pseudoephedrine hydrochloride 6 mg/mL oral solution	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Brompheniramine maleate	Inferred relationship	Some	2
Brompheniramine maleate 400 microgram/mL and codeine phosphate 2 mg/mL and phenylpropanolamine hydrochloride 2.5 mg/mL oral solution	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Brompheniramine maleate	Inferred relationship	Some	2
Brompheniramine maleate 400 microgram/mL and codeine phosphate 2 mg/mL and phenylpropanolamine hydrochloride 2.5 mg/mL oral solution	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Brompheniramine maleate	Inferred relationship	Some	2
Product containing precisely brompheniramine maleate 400 microgram/1 milliliter and dextromethorphan hydrobromide 2 milligram/1 milliliter and phenylpropanolamine hydrochloride 2.5 milligram/1 milliliter conventional release oral solution (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Brompheniramine maleate	Inferred relationship	Some	1
Product containing precisely brompheniramine maleate 400 microgram/1 milliliter and dextromethorphan hydrobromide 2 milligram/1 milliliter and phenylpropanolamine hydrochloride 2.5 milligram/1 milliliter conventional release oral solution (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Brompheniramine maleate	Inferred relationship	Some	1
Product containing precisely brompheniramine maleate 3 milligram and caffeine 30 milligram and paracetamol 325 milligram/1 each conventional release oral tablet (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Brompheniramine maleate	Inferred relationship	Some	2
Product containing precisely brompheniramine maleate 3 milligram and caffeine 30 milligram and paracetamol 325 milligram/1 each conventional release oral tablet (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Brompheniramine maleate	Inferred relationship	Some	2

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
49500015	Brompheniramine maleate	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
49501016	Parabromdylamine maleate	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
760498010	Brompheniramine maleate (substance)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
2659531000005115	Brompheniraminmaleat	da	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	Danish module (core metadata concept)